Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Special MTA: None
ATGGCCGAGGAGCCGAGGGCGCCAGAGGCGCTCTCGTCCACGTTCATGTTGAACATGACC
TCAGACGCCTCCGTGAGGCGTATAGTCAGGAGGATAGGGACCCTGGCTAGGCGCCGCGTC
CAACAACTCCCGGATATGGAGACGTTCTCCCCCGAGTTTGACCCGGAGCTCTCGGAGCCC
CCCTTCCTGCCCTTTTCAGCCTATGTAATTACGGGAACGGCGGGGGCTGGCAAGAGCACC
AGCGTTAGCTGCCTCCACCACACGATGGACTGCCTGGTCACGGGAGCCACAACCGTGGCC
GCACAGAACCTCTCCCAGACACTCCGAGCCTACTGCCCAACCGTCTATAGCGCCTTTGGG
TTCAAGAGCCGCCACATAAATATGACGCAGCGGGTCAGCAGTCATGGTCGCTCTACGGAC
GCCGCCCTAGAGGAACTCCAGCGGCGGGACCTGGCCAAATACTGGCCGGTACTCTCCGAC
ATTGCCGCCGAGTTCAGGCGAACCAAGCCCAGGGGGCTCTACTCGGGAGTCTCTGGCCCC
GCCTTTGAGGTCCTGAGAGACATGCACCAGGGGCAGCTATGGACCACCAATGTGATCGTG
GTGGACGAAGCTGGAACGCTTTCCGTGCACATTCTAACAGCCGTGGTCTTTTGCTACTGG
TTCTTCAACGCCTGGCTGCGTACCCCACTCTACCGCCGGGGCCGCATTCCCTGCATCGTC
TGCGTGGGCTCTCCCACCCAGACAGACGCCTTTCAGTCCTCCTTTAGCCACGAGACCCAG
GTAAACAAGATTCGCGAGTGCGACAACATCCTCACCTTCCTGGTGGGCAACCCCAGGGCC
GCGACCTACGTGGACGTGGCCCGCAACTGGGCCCTCTTCATCAACAACAAGCGCTGCACC
GACGTCCAGTTTGGACACCTCATGAAGACCCTCGAGTACGGCCTCGAGCTCTCGCCGGAC
ATCCTGGCCTACGTCGACCGCTTCGTCGTCCCCAGGGCGGCCATAATGGACCCCGCGCAG
TACGTGGGCTGGACCCGGCTCTTCCTCTCCCACGCCGAGGTCAAGACCTTCCTCACCACC
CTCCATGCCACGCTCAAGACTGCCGGGCAGGGGCGTGCCGCGCGGGGAACCGGGGGAGAT
GGGGGCGGGGTGACCATGTTTACCTGCCCGGTGGAGTGCGAGGTCTTCCTCGATCCCCTG
GCCCAGTACAAGACCCTGGTCGGGCTTCCGGGCCTCACGGCCCACACCTGGCTCCAAAAG
AATTATGCACGCCTCGGTAACTACTCGCAGTTCGCCGACCAAGACATGGTCCCGGTGGGC
ACCGAGCAGGACGAAGAACGGGTCAAGGTCACCTACAATGTCACCTACGTCAAGCACAGC
TCGGTGTCGGTCAACTGCAAGACCAAAAAGTCCATCTGTGGCTATACCGGCACCTTCGGG
GACTTTATGGACACGCTCGAGGCGGACAGCTTCGTGGAGGCCCACGGGCATGAGCAGCCC
GAGTATGTCTACAGCTTCCTGGCCCGACTCATCTACGGAGGCATCTACGCTTTTAGCCAC
GGAGGACATTCTCTCTGTGAAAACGGGGAATACGTGGCGGAGCTTGGTGCTGTGCCCCTG
CCCGGGCGTACGTGGGATCCGGAGGTGACTGCTGGGATGGAGCTGGGCGAACTGCCGCTG
GAGGTTGCCTGGGATGGGGAGCGGAGCCCCGCCGCTGTCTTCTATGCCCGAGTACTGGCT
CCCCCGGCCGCAAATTCTGCCCCCCTCTGCTCCCTGTTAAACATATATAATGACCTCAGG
GCCTATTTCAGGCAATGCCTGGATGTGGCCGTCCGCTATGGCGGAAGGGAGTTCAGGGAC
CTCCCCTTCTGCACATTTACCAACAACATGCTGATTCGCGACAACATAGAGTTCACCTCA
GACGAGCCTCTCCTTCACGGCCTCCTGGACTACGCCTCCACCACCGAGAACTACACGCTT
CTGGGCTACACGCATCTCAACGTCTTCTTTGGCATCCGAGGAAAGCAGCAGCCTCAGGAC
GCTGGCAGTTCACGCATGCCCAGGCTAATGGTCAAGGATGAGGCAGGCTTCGTGTGCTGC
CTGGAACACAATACTAACAAACTGTATGAGACGATAGAGGACAAGTCCCTGAACCTCTGC
AGCATCCGTGACTATGGCATTAGCTCAAAGCTGGCCATGACCATAGCCAAGGCCCAGGGT
CTGTCCCTAAACAAAGTCGCCATCTGCTTCGGCAGCCACAGAAACATCAAACCCGGCCAT
GTGTATGTGGCGCTGTCCCGGGCCCGGCACTCTAATTGCGTGGTCATGGACAGGAATCCC
CTATCCGAGATGATCACTGGGGAGGGGAACCCCGCGAGCGGCTACATCGTGGATGCCCTA
AAGAACTCACGCGCACTACTGGTTTACTGA
MAEEPRAPEALSSTFMLNMTSDASVRRIVRRIGTLARRRVQQLPDMETFSPEFDPELSEP PFLPFSAYVITGTAGAGKSTSVSCLHHTMDCLVTGATTVAAQNLSQTLRAYCPTVYSAFG FKSRHINMTQRVSSHGRSTDAALEELQRRDLAKYWPVLSDIAAEFRRTKPRGLYSGVSGP AFEVLRDMHQGQLWTTNVIVVDEAGTLSVHILTAVVFCYWFFNAWLRTPLYRRGRIPCIV CVGSPTQTDAFQSSFSHETQVNKIRECDNILTFLVGNPRAATYVDVARNWALFINNKRCT DVQFGHLMKTLEYGLELSPDILAYVDRFVVPRAAIMDPAQYVGWTRLFLSHAEVKTFLTT LHATLKTAGQGRAARGTGGDGGGVTMFTCPVECEVFLDPLAQYKTLVGLPGLTAHTWLQK NYARLGNYSQFADQDMVPVGTEQDEERVKVTYNVTYVKHSSVSVNCKTKKSICGYTGTFG DFMDTLEADSFVEAHGHEQPEYVYSFLARLIYGGIYAFSHGGHSLCENGEYVAELGAVPL PGRTWDPEVTAGMELGELPLEVAWDGERSPAAVFYARVLAPPAANSAPLCSLLNIYNDLR AYFRQCLDVAVRYGGREFRDLPFCTFTNNMLIRDNIEFTSDEPLLHGLLDYASTTENYTL LGYTHLNVFFGIRGKQQPQDAGSSRMPRLMVKDEAGFVCCLEHNTNKLYETIEDKSLNLC SIRDYGISSKLAMTIAKAQGLSLNKVAICFGSHRNIKPGHVYVALSRARHSNCVVMDRNP LSEMITGEGNPASGYIVDALKNSRALLVY*
Coding Sequence Details
Recommended Growth Condition: